AVAlexander D. Verin

Alexander D. Verin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexander D. Verin has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Joe G.N. Garcia

    Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

    5 shared publications
  • Anna A. Birukova

    Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA

    3 shared publications
  • Irina A. Kolosova

    Johns Hopkins University

    2 shared publications
  • Konstantin G. Birukov

    Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

    2 shared publications
  • Peter Usatyuk

    Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

    2 shared publications
  • Viswanathan Natarajan

    Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland

    2 shared publications

Latest Publications

  • Potential Protein Partners for the Human TIMAP Revealed by Bacterial Two-hybrid Screening

    by Djanybek M. Adyshev, Irina A. Kolosova, Alexander D. Verin

    BacterioMatch Two-Hybrid System (Stratagene) was applied in order to identify potential human TIMAP interaction proteins in the lung. TIMAP highly expressed in endothelial cells and may be involved in endothelial cytoskeletal and barrier regulation. Seven TIMAP interacting partner proteins were identified. Four of identified proteins: cystein and glycine-rich protein 1, eukaryotic translation elongation factor 2, U5 snRNP-specific protein 116 kD, and solute carrier family 3 member 2 are involved in actin cytoskeleton organization, cell adhesion or translation and transcriptional regulation.


  • Involvement of microtubules and Rho pathway in TGF‐β1‐induced lung vascular barrier dysfunction

    by Anna A. Birukova, Konstantin G. Birukov, Djanibek Adyshev, Peter Usatyuk, Viswanathan Natarajan, Joe G.N. Garcia, Alexander D. Verin

    Transforming growth factor‐β1 (TGF‐β1) is a cytokine critically involved in acute lung injury and endothelial cell (EC) barrier dysfunction. We have studied TGF‐β1‐mediated signaling pathways and examined a role of microtubule (MT) dynamics in TGF‐β1‐induced actin cytoskeletal remodeling and EC barrier dysfunction. TGF‐β1 (0.1–50 ng/ml) induced dose‐dependent decrease in transendothelial electrical resistance (TER) in bovine pulmonary ECs, which was linked to increased actin stress fiber formation, myosin light chain (MLC) phosphorylation, EC retraction, and gap formation. Inhibitor of TGF‐β1 receptor kinase RI (5 μM) abolished TGF‐β1‐induced TER decline, whereas inhibitor of caspase‐3 zVAD (10 μM) was without effect. TGF‐β1‐induced EC barrier dysfunction was linked to partial dissolution of peripheral MT meshwork and decreased levels of stable (acetylated) MT pool, whereas MT stabilization by taxol (5 μM) attenuated TGF‐β1‐induced barrier dysfunction and actin remodeling. TGF‐β1 induced sustained activation of small GTPase Rho and its effector Rho‐kinase; phosphorylation of myosin binding subunit of myosin specific phosphatase; MLC phosphorylation; EC contraction; and gap formation, which was abolished by inhibition of Rho and Rho‐kinase, and by MT stabilization with taxol. Finally, elevation of intracellular cAMP induced by forskolin (50 μM) attenuated TGF‐β1‐induced barrier dysfunction, MLC phosphorylation, and protected the MT peripheral network. These results suggest a novel role for MT dynamics in the TGF‐β1‐mediated Rho regulation, EC barrier dysfunction, and actin remodeling.


  • The role of caldesmon in the regulation of endothelial cytoskeleton and migration

    by Tamara Mirzapoiazova, Irina A. Kolosova, Lew Romer, Joe G.N. Garcia, Alexander D. Verin

    The actin‐ and myosin‐binding protein, caldesmon (CaD) is an essential component of the cytoskeleton in smooth muscle and non‐muscle cells and is involved in the regulation of cell contractility, division, and assembly of actin filaments. CaD is abundantly present in endothelial cells (EC); however, the contribution of CaD in endothelial cytoskeletal arrangement is unclear. To examine this contribution, we generated expression constructs of l‐CaD cloned from bovine endothelium. Wild‐type CaD (WT‐CaD) and truncated mutants lacking either the N‐terminal myosin‐binding site or the C‐terminal domain 4b (containing actin‐ and calmodulin‐binding sites) were transfected into human pulmonary artery EC. Cell fractionation experiments and an actin overlay assay demonstrated that deleting domain 4b, but not the N‐terminal myosin‐binding site, resulted in decreased affinity to both the detergent‐insoluble cytoskeleton and soluble actin. Recombinant WT‐CaD co‐localized with acto‐myosin filaments in vivo, but neither of CaD mutants did. Thus both domain 4b and the myosin‐binding site are essential for proper localization of CaD in EC. Overexpression of WT‐CaD led to cell rounding and formation of a thick peripheral subcortical actin rim in quiescent EC, which correlated with decreased cellular migration. Pharmacological inhibition of p38 MAPK, but not ERK MAPK, caused disassembly of this peripheral actin rim in CaD‐transfected cells and decreased CaD phosphorylation at Ser531 (Ser789 in human h‐CaD). These results suggest that CaD is critically involved in the regulation of the actin cytoskeleton and migration in EC, and that p38 MAPK‐mediated CaD phosphorylation may be involved in endothelial cytoskeletal remodeling.


  • Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: Role of Rho‐dependent mechanisms

    by Anna A. Birukova, Ksenya Smurova, Konstantin G. Birukov, Peter Usatyuk, Feng Liu, Kozo Kaibuchi, Anila Ricks‐Cord, Viswanathan Natarajan, Irina Alieva, Joe G.N. Garcia, et al.

    Barrier dysfunction of pulmonary endothelial monolayer is associated with dramatic cytoskeletal reorganization, activation of actomyosin contractility, and gap formation. The linkage between the microtubule (MT) network and the contractile cytoskeleton has not been fully explored, however, clinical observations suggest that intravenous administration of anti‐cancer drugs and MT inhibitors (such as the vinca alkaloids) can lead to the sudden development of pulmonary edema in breast cancer patients. In this study, we investigated the crosstalk between MT and actomyosin cytoskeleton and characterized specific molecular mechanisms of endothelial cells (EC) barrier dysfunction induced by MT inhibitor nocodazole (ND). Our results demonstrate that MT disassembly by ND induced rapid decreases in transendothelial electrical resistance (TER) and actin cytoskeletal remodeling, indicating EC barrier dysfunction. These effects involved ND‐induced activation of Rho GTPase. Rho‐mediated activation of its downstream target, Rho‐kinase, induced phosphorylation of Rho‐kinase effector EC MLC phosphatase (MYPT1) at Thr696 and Thr850 resulting in MYPT1 inactivation. Phosphatase inhibition leaded to accumulation of diphospho‐MLC, which induced acto‐myosin polymerization, stress fiber formation and gap formation. Inhibition of Rho‐kinase by Y27632 abolished ND‐induced MYPT1 phosphorylation, MLC phosphorylation, and stress fiber formation. In addition, MT preservation via the MT stabilizer paclitaxel, Rho inhibition (via C3 exotoxin, or dominant negative (DN)‐Rho, or DN‐Rho‐kinase) attenuated ND‐induced TER decreases, stress fiber formation and MLC phosphorylation. Collectively, our results demonstrate a leading role for Rho‐dependent mechanisms in crosstalk between the MT and actomyosin cytoskeleton, and suggest Rho‐kinase and MYPT1 as major Rho effectors mediating pulmonary EC barrier disruption in response to ND‐induced MT disassembly. J. Cell. Physiol. 201: 55–70, 2004.


  • Phosphatase 2A is involved in endothelial cell microtubule remodeling and barrier regulation

    by Krisztina Tar, Anna A. Birukova, Csilla Csortos, Éva Bakó, Joe G.N. Garcia, Alexander D. Verin

    We have recently shown that microtubule (MT) inhibitor, nocodazole (2–5 μM) significantly increases endothelial cells (EC) actomyosin contraction and permeability indicating the importance of MT in maintaining the EC barrier (Verin et al. [2001]: Cell Mol Physiol 281:L565–L574). Okadaic acid (OA, 2–5 nM), a powerful inhibitor of protein phosphatase 2A (PP2A), significantly potentiates the effect of submaximal concentrations of nocodazole (50–200 nM) on transendothelial electrical resistance (TER) suggesting the involvement of PP2A activity in the MT‐mediated EC barrier regulation. Immunofluorescent staining of EC revealed that in control cells PP2A distributes in a pattern similar to MT. Consistent with these results, we demonstrated that significant amounts of PP2A were present in MT‐enriched EC fractions indicating tight association of PP2A with MT in endothelium. Treatment of EC with OA leads to disappearance of MT‐like PP2A staining suggesting dissociation of PP2A from the MT network. Next, we examined the effect of PP2A inhibition on phosphorylation status of MT‐associated protein tau, which in its unphosphorylated form promotes MT assembly. OA caused significant increases in tau phosphorylation confirming that tau is a substrate for PP2A in endothelium. Immunofluorescent experiments demonstrated that the OA‐induced increases in tau phosphorylation strongly correlated with translocation of phospho‐tau to cell periphery and disassembly of peripheral MT. These results suggest the involvement of PP2A‐mediated tau dephosphorylation in alteration of EC MT structure and highlight the potential importance of PP2A in the regulation of EC the MT cytoskeleton and barrier function.


  • Role of tyrosine kinase signaling in endothelial cell barrier regulation

    by Natalia V. Bogatcheva, Joe G.N. Garcia, Alexander D. Verin